5-Bromo-3-indolyl β-D-galactopyranoside
5-Bromo-3-indolyl β-D-galactopyranoside structure
|
Common Name | 5-Bromo-3-indolyl β-D-galactopyranoside | ||
|---|---|---|---|---|
| CAS Number | 97753-82-7 | Molecular Weight | 374.184 | |
| Density | 1.8±0.1 g/cm3 | Boiling Point | 646.6±55.0 °C at 760 mmHg | |
| Molecular Formula | C14H16BrNO6 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 344.9±31.5 °C | |
Use of 5-Bromo-3-indolyl β-D-galactopyranoside5-Bromo-3-indolyl β-D-galactopyranoside (Bluo-Gal) is a chromogenic substrate to detect bacterial β-D-galactosidase activity. 5-Bromo-3-indolyl β-D-galactopyranoside is used both to recognize labelled myofibers, and beta-gal positive organelles inside single myofibers[1]. |
| Name | 5-Bromo-3-indolyl-β-D-galactopyranoside |
|---|---|
| Synonym | More Synonyms |
| Description | 5-Bromo-3-indolyl β-D-galactopyranoside (Bluo-Gal) is a chromogenic substrate to detect bacterial β-D-galactosidase activity. 5-Bromo-3-indolyl β-D-galactopyranoside is used both to recognize labelled myofibers, and beta-gal positive organelles inside single myofibers[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 646.6±55.0 °C at 760 mmHg |
| Molecular Formula | C14H16BrNO6 |
| Molecular Weight | 374.184 |
| Flash Point | 344.9±31.5 °C |
| Exact Mass | 373.016083 |
| PSA | 115.17000 |
| LogP | 0.11 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.731 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xn |
| Risk Phrases | R20/21/22 |
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2934999090 |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
All-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines.
J. Virol. 88(17) , 10013-25, (2014) Vaccination is the first line of defense against influenza virus infection, yet influenza vaccine production methods are slow, antiquated, and expensive as a means to effectively reduce the virus burd... |
|
|
Cellular transformation of mouse embryo fibroblasts in the absence of activator E2Fs.
J. Virol. 89(9) , 5124-33, (2015) The E2F family of transcription factors, broadly divided into activator and repressor E2Fs, regulates cell cycle genes. Current models indicate that activator E2Fs are necessary for cell cycle progres... |
|
|
Evaluation of new medium with chromogenic substrates for members of the family Enterobacteriaceae in urine samples.
J. Clin. Microbiol. 33(1) , 199-201, (1995) A new medium containing 5-bromo-4-chloro-3-indolyl-beta-D-glucuronide cyclohexylammonium salt (Glu agar) for Escherichia coli and a new medium containing 5-bromo-3-indolyl-beta-D-galactoside (Gal agar... |
| 5-Bromo-1H-indol-3-yl β-D-galactopyranoside |
| MFCD00063691 |
| β-D-Galactopyranoside, 5-bromo-1H-indol-3-yl |
| acirc-D-galactoside |
| BLUO-GAL |
| 5-BROMO-3-INDOLYL-B-D-GALACTOSIDE |
| BLUE-GAL |
| 5-Bromo-3-indolyl-b-D-galactopyranoside |